Abstract
Bronchopulmonary dysplasia (BPD) remains a major cause of morbidity and mortality in premature infants, and despite many advances, its pathophysiology remains incompletely understood. Exposure of the premature lung to hyperoxia is commonly implicated in its pathogenesis. However, the exact link between hyperoxia and BPD, particularly its role in the generation of myofibroblasts, the signature cell-type for lung fibrosis, is undetermined. There is increasing evidence that lipid interstitial fibroblasts play an important role in injury-repair mechanisms in various organ systems. This study demonstrates that exposure to hyperoxia augments the transdifferentiation of pulmonary lipofibroblasts to myofibroblasts. Fetal rat lung fibroblasts (ERLF) from embryonic (e) (term=e22) 18 and e21 gestation were studied. After initial culture in minimum essential medium (MEM) and 10% fetal bovine serum (FBS) in 21% O2/5% CO2 at 37°C, FRLF were maintained in MEM and 10% FBS at 37°C under control (21% O2/5% CO2) and under experimental conditions (24-hour exposure to 95% O2/5% CO2) at passage (P) 1 and 5. At each passage, cells were allowed to attach to 100 cm2 culture dishes and grow in 21% O2 before being subjected to the experimental conditions. Passage 1 and 5 cells were analyzed for the expression of well-characterized lipogenic and myogenic markers based on semiquantitative competitive RT-PCR (for parathyroid hormone-related protein receptor [PTHrPR]), adipose differentiation related protein (ADRP), and α smooth muscle actin (αSMA), triglyceride uptake, and leptin assay. Serial passage and maintenance of cells in 21% O2 resulted in a significant decrease in the expression of the lipogenic markers from P1 to P5, spontaneously. This decrease was greater for e18 than for e21 FRLF. However, exposing cells to 95% O2 augmented the loss of the lipogenic markers and gain of the myogenic marker from P1 to P5 in comparison to cells maintained in 21% O2. These changes were also greater for e18 vs e21 lipofibroblasts. These changes in mRNA expression were accompanied by decreased triglyceride uptake and leptin secretion on exposure to hyperoxia. These results suggest that exposure to hyperoxia (95% O2) augments the transdifferentiation of pulmonary lipofibroblasts to myofibroblasts. Hyperoxia-augmented transdifferentiation was at least partially attenuated by prostaglandin J2 pretreatment. Lipofibroblast-to-myofibroblast transdifferentiation may be an important mechanism for hyperoxic lung injury and may be an important element in the pathophysiology of BPD. In addition, induction of adipogenic transcription factors may not only prevent but, in fact, may reverse the myogenic fibroblast phenotype to the adipogenic fibroblast phenotype.
Similar content being viewed by others
References
Stevenson, D. K., Wright, L. L., Lemons, J. A., et al. (1998) Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network January 1993 through December 1994. Am. J. Obstet. Gynecol. 179, 1632–1639.
Warner, B. B., Stuart, R. A., Papes, R. A., and Wispe, J. R. (1998) Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am. J. Physiol. 275, L110-L117.
Saugstad, O. D. (2001) Chronic lung disease: oxygen dogma revisited. Acta Paediatr. 90, 113–115.
Fardy, C. H. and Silverman, M. (1995) Antioxidants in neonatal lung disease. Arch. Dis. Child. Fetal. 73, F112-F117.
Coalson, J. J., Winter, V., and deLemos, R. A. (1995) Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 152, 640–646.
Jobe, A. J. (1999) The new BPD: An arrest of lung development. Pediatr. Res. 46, 641–643.
Husain, N. A., Siddiqui, N. H., and Stocker, J. R. (1998) Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum. Pathol. 29, 710–717.
Torday, J. S., Torres, E., and Rehan, V. K. (2003) The role of fibroblast transdifferentiation in lung epithelial cell proliferation, differentiation and repair. Pediatr. Pathol. Mol. Med. 22, 189–207.
Phan, S. H., Zhang, K., Zhang, H. Y., and Gharaee-Kermani, M. (1999) The myofibroblast as an inflammatory cell in pulmonary fibrosis. Curr. Top. Pathol. 93, 173–182.
Gauldie, J., Sime, P. J., Xing, Z., Marr, B., and Tremblay, G. M. (1997) Transforming growth factor-beta gene transfer to the lung induces myofibroblast presence and pulmonary fibrosis. Curr. Top. Pathol. 93, 35–45.
Toti, P., Buonocore, G., Tanganelli, P., et al. (1997) Bronchopulmonary dysplasia of the premature baby: an immunohistochemical study. Pediatr. Pulmonol. 24, 22–28.
Rehan, V. K., Ling, W., Feng, S., Rehan, Y. H., and Torday, J. S. (2001) Hyperoxia augments pulmonary transdifferentiation to myofibroblasts. Baltimore, Academy of Pediatric, Societies A1716.
Boros, L. G., Torday, J. S., Lee, W.-N., and Rehan, V. K. (2002) Metabolic characterization of oxygen triggered transdifferentiation in immature rat fetal lung fibroblast. Mol. Genet. Metab. 77, 230–236.
Martinet, Y., Menard, O., Vaillant, P., Vignaud, J. M., and Martinet, N. (1996) Cytokines in human lung fibrosis. Arch. Toxicol. Suppl. 18, 127–139.
Dooley, S., Delvoux, B., Lahme, B., Mangasser-Stephan, K., and Gressner, A. M. (2000) Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology 31, 1094–1096.
Shimizu, E., Kobayashi, Y., Oki, Y., Kawasaki, T., Yoshimi, T., Nakamura, H. (1999) OPC-13013, a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells. Life Sci. 64, 2081–2088.
McGowan, S. E. and Torday, J. S. (1997) The pulmonary lipofibroblast (lipid interstitial cell) and its contributions to alveolar development. Annu. Rev. Physiol. 59, 43–62.
Sugahara, K., Mason, R. J., and Shannon, J. M. (1998) Effects of soluble factors and extracellular matrix on DNA synthesis and surfactant gene expression in primary cultures of rat alveolar type II cells. Cell Tissue Res. 291, 295–303.
Lebeche, D., Malpel, S., and Cardoso, W. V. (1999) Fibroblast growth factor interactions in the developing lung. Mech. Dev. 86, 125–136.
Adamson, I. Y., Young, L., and King, G. M. (1991) Reciprocal epithelial: fibroblast interactions in the control of fetal and adult rat lung cells in culture. Exp. Lung Res. 17, 821–835.
Shannon, J. M., Pan, T., Nielsen, L. D., Edeen, K. E., and Mason, R. J. (2001) Lung fibroblasts improve differentiation of rat type II cells in primary culture. Am. J. Respir. Cell. Mol. Biol. 24, 235–244.
Smith, B. T. and Post, M. (1989) Fibroblast-pneumonocyte factor. Am. J. Physiol. 257, L174-L178.
O'Reilly, M. A., Stripp, B. R., and Pryhuber, G. S. (1997) Epithelial-mesenchymal interactions in the alteration of gene expression and morphology following lung injury. Microsc. Res. Tech. 38, 473–479.
Heath, V. J., Gillespie, D. A., and Crouch, D. H. (2000) Inhibition of the terminal stages of adipocyte differentiation by cMyc. Exp. Cell Res. 254, 91–98.
Bruce, M. C., Honaker, C. E., and Cross, R. J. (1999) Lung fibroblasts undergo apoptosis following alveolarization. Am. J. Respir. Cell Mol. Biol. 20, 228–236.
Gressner, A. M. (1996) Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis. Kidney Int. Suppl. 54, S39-S45.
Torday, J. S., Torday, D. P., Gutnick, J., and Rehan, V. (2001) Biologic role of fetal lung fibroblast triglycerides as antioxidants. Pediatr. Res. 49, 1–7.
Chomczynski, P. and Sacchi, N. (1987) Single step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction. Anal Biochem. 162, 156–159.
Torday, J. S. and Rehan, V. K. (2000) Stretchstimulated surfactant phospholipid synthesis is mediated by the coordinated paracrine actions of parathyroid hormone-related protein and leptin. Am. J. Physiol. Lung Cell Mol. Physiol. 283, L130-L135.
Torday, J., Hua, J., and Slavin, R. (1995) Metabolism and feta of neutral lipids of fetal lung fibroblast origin. Biochim. Biophys. Acta 1254, 198–206.
Mendelson, C. R. (2000) Endocrinology of the Lung. Humana, Totowa, NJ.
Rubin, L. P., Sanchez-Esteban, J., Chinoy, M., Qin, J., and Torday, J. S. Transduction of mechanical signals by parathyroid hormone-related protein promotes pulmonary alveolar differentiation. J. Appl Physiol., in press.
Rubin, L. P., Kifor, O., Hua, J., Brown, E. M., and Torday, J. S. (1994) Parathyroid hormone (PTH) and PTH-related protein stimulate surfactant phospholipid synthesis in rat fetal lung, apparently by a mesenchymal-epithelial mechanism. Biochim. Biophys. Acta. 1223, 91–100.
Rubin, L. P. and Torday, J. S. (2000) Parathyroid hormone-related Protein (PTHrP) biology in fetal lung development, in Endocrinology of the Lung. Humana, Totowa, NJ, pp. 269–297.
Londos, C., Brasaemle, D. L., Schultz, C. J., Segrest, J. P., and Kimmel, A. R. (1999) Perilipins, ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells. Semin. Cell. Dev. Biol. 10, 51–58.
Schultz, C. J., Londos, C., Sun, H., Torres, E., and Torday, J. S. (2002) Role of adipocyte differentiation-related protein in surfactant phospholipid synthesis by type II cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 283, L288-L296.
Gille J. J. and Joenje, H. (1992) Cell culture models for oxidative stress: superoxide and hydrogen peroxide versus normobaric oxygen. Mutat. Res. 275, 405–414.
Hashimoto, S., Gon, Y., Takeshita, I., Matsumoto, K., Maruoka, S., and Horie, T. (2001) Transforming growth factor—β1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway. Am. J. Respir. Crit. Care. 163, 152–157.
Gao, J. and Serrero, G. (1999) Adipose differentiation related protein (ADRP) expressed in transfected COS-7 cells selectively stimulates long chain fatty acid uptake. J. Biol. Chem. 274, 16825–16830.
Dooley, S., Delvoux, B., Lahme, B., Mangasser-Stephan, K., and Gressner, A. M. (2000) Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology 31, 1094–1106.
Shimizu, E., Kobayashi, Y., Oki, Y., Kawasaki, T., Yoshimi, T., and Nakamura, H. (1999) OPC-13013 a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells. Life Sci. 64, 2081–2088.
Potter, J. J., Rennie-Tankersley, L., Anania, F. A., and Mezey, E. (1999) A transient increase in c-mycprecedes the transdifferentiation of hepatic stellate cells to myofibroblast-like cells. Liver 19, 135–144.
Weber, K. T. (1997) Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair. Semin. Nephrol. 17, 467–491.
Tang, W. W., Van, G. Y., and Qi, M. (1997) Myofibroblast and alpha 1 (III) collagen expression in experimental tubulointerstitial nephritis. Kidney Int. 51, 926–931.
Marra, F., Efsen, E., Romanelli, R. G., et al. (2000) Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology. 119, 466–478.
Galli, A., Crabb, D., Price, D., et al. (2000) Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatology. 31, 101–108.
Heath, V. J., Gillespie, D. A., and Crough, D. H. (2000) Inhibition of the terminal stages of adipocyte differentiation by cMyc. Exp. Cell. Res. 254, 91–98.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported in part by American Heart Association grant (no. 0265127Y) to V.K.R. and National Institutes of Health grant (HL 55268) to J.S.T. and V.K.R.
Rights and permissions
About this article
Cite this article
Rehan, V.K., Torday, J.S. Hyperoxia augments pulmonary lipofibroblast-to-myofibroblast transdifferentiation. Cell Biochem Biophys 38, 239–249 (2003). https://doi.org/10.1385/CBB:38:3:239
Issue Date:
DOI: https://doi.org/10.1385/CBB:38:3:239